SlideShare a Scribd company logo
1 of 28
EFFICACY OF VAGINAL VS. ORAL MISOPROSTOL FOR
    INDUCTION OF LABOR IN MISSED ABORTION



                PRESENTED BY
          Lugansk State Medical University Block
             50 years, Of lugansk defence, 1.
               Lugansk - 91045, Ukraine.
               email : info@lsmuedu.com /
                   kanc@lsmuedu.com
                     Official website -
                http://www.lsmuedu.com
                                                   1
                   +38-091-9484-428
OBJECTIVES
   TO DETERMINE THE EFFICACY OF
    VAGINAL VS. ORAL MISOPROSTOL AS A
    LABOR INDUCING AGENT IN MISSED
    ABORTION.




                                        2
INTRODUCTION

 MISSED ABORTION IS THE FAILURE TO
  EXPEL THE PRODUCTS OF CONCEPTION
  AFTER DEATH OF EMBRYO.
 MISSED ABORTION IS MANAGED EITHER
  BY SURGICAL & NON SURGICAL
  METHODS.
 IN RECENT YEARS MISOPROSTOL,A
  SYNTHETIC PGE1, ANALOGUE, IS BEING   3

  EVALUATED FOR LABOR INDUCTION.
4
INTRODUCTION:
 MISOPROSTOL CAN BE GIVEN ORALLY,
  SUBLINGUALLY, VAGINALLY OR
  RECTALLY.
 IT HAS BEEN EXTENSIVELY STUDIED &
  USED FOR OBSTETRICAL &
  GYNAECOLOGICAL CAUSES, SUCH AS
  PRE-INDUCTION CERVICAL RIPENING,
  LABOR INDUCTION, EVACUATION OF
  UTERUS AFTER PREGNANCY FAILURE OR
  VARIOUS MEDICAL REASONS.
                                      5
DESIGN


   A QUASI EXPERIMENTAL STUDY.




                                  6
SUBJECT &SETTING:
 THIS STUDY WAS PERFORMED IN
  GYNAE/OBS UNIT II IN HOLY FAMILY
  HOSPITAL RAWALPINDI [PAKISTAN].
 35 PATIENTS IN VAGINAL MISOPROSTOL
  GROUP & 35 PATIENTS IN ORAL
  MISOPROSTOL GROUP WERE STUDIED.



                                       7
METHOD:
 TOTAL OF 70 PREGNANT WOMEN
  ADMITTED WITH MISSED ABORTION OR
  BLIGHTED OVUM OF 8wks TO 24wks OF
  GESTATION DURING THE PERIOD OF
  JUNE 2005 TO NOV 2005.
 MISSED ABORTION WAS CONFIRMED ON
  ULTRASOUND.
 INITIAL EVALUATION OF PTS WAS DONE.
 CONSENT OF PATIENT.
                                    8
METHODS:
 THE CASES WERE RANDOMIZED IN TWO
  GROUPS.
 ONE FOR ORAL MISOPROSTOL & OTHER
  FOR VAGINAL MISOPROSTOL.
 IN ONE GROUP 400ug WAS INSERTED
  UNDER FULL ASEPTIC CONDITIONS HIGH
  UP IN POSTERIOR FORNIX OF VAGINA
  WHILE IN SECOND GROUP PATIENT TAKE
  IT ORALLY.
                                   9
10
METHODS:
 THE DOSE OF MISOPROSTOL WAS
  REPEATED AFTER EVERY 4hrs TO A MAX.
  OF FOUR DOSES IN 24 hrs.
 IF COMPLETE EXPULSION DID NOT
  OCCUR WITH IN 48hrs & IF PATIENT
  BLEED HEAVILY THEN ERPC WAS DONE.
 FOLLOW UP.


                                        11
RESULTS: [PATIENTS
DISTRIBUTION IN BOTH GROUP]
 35
 35




       Vaginal Misoprostol   ORAL Misoprostol
                                                12
RESULTS [AGE OF PATIENT]
80


70


60


50


40


30


20


10


 0
     <20 years   20-30 years      >35 years


      Oral Misoprostol         Vaginal Misoprostol

                                                     13
RESULTS: [PARITY]

   60
    50
    40
    30
    20                    Oral
    10                    Misoprostol
     0
          Prim igravida




                          Vaginal
                          Misoprostol




                                        14
RESULTS:
            VAGINAL       ORAL
            Misoprostol   Misoprostol
            GROUP         GROUP
MEAN
INDUCTION
TO          9.16 HRS      12.09HRS
EXPULSION
TIME

                                        15
RESULTS: [INDUCTION TO
       EXPULSION TIME]





                                                 16

        Oral Misoprostol   Vaginal Misoprostol
RESULTS:
OTHER        VAGINAL    ORAL GROUP
MEASURE      GROUP
             3%         7%
ERPC
[REQUIRED]   21%        27%

COMPLETE
EXPULTION    52%        28%

                                 17
RESULTS: [REQUIREMENT FOR
       ERPC IN BOTH GROUP]

           52
           51
           50
           49
           48            .
           47
           46
                        ERPC

                                               18

     Oral misoprostol    Vaginal Misoprostol
RESULTS: [REQUIRMENT OF
OXYTOCIN AUGMENTATION]



                                                 Vaginal Misoprostol




                                                 Oral Misoprostol




        Oral Misoprostol   Vaginal Misoprostol


                                                                       19
RESULTS: [COMPARISON OF
  ERPC & OXYTOCIN FOR
 COMPLETE EVACUATION]
   100%

   80%

   60%

   40%

   20%

    0%

      Oral Misoprostol   Vaginal Misoprostol

                                               20
COMPLICATIONS: [IN BOTH
           GROUPS]



                                                                       Vaginal
                                                                      Misoprostol
                                                                      Oral Misoprostol




                                         termination


                                                       complication
          fever


                  vomoting


                             diarrhoea

                                            faild


                                                           no
             Oral Misoprostol               Vaginal Misoprostol




                                                                                         21
DISCUSSION:
 TERMINATION OF PREGNANCY IS AN
  INTEGRAL PART OF ANY
  GYNAECOLOGICAL PRACTICE.
 DIFFERENT METHODS OF CERVICAL
  RIPENING HAVE BEEN USED WITH
  VARIABLE RESULTS.
 CHOHAN,etal, HAVE DONE A STUDY
  USING EXTRA AMNIOTIC PGF2 alpha FOR
  MID TRIMESTER INDUCTION OF LABOR
  IN PTS WITH LATE MISSED ABORTION.
                                    22
DISCUSSION:
 THEY CLAIMED THAT 100% EXPULSION
  RATE WHICH IS COMPARABLE TO 94%
  EXPULSION RATE OBSERVED IN OUR
  STUDY.
 MUFFLEY PE,[2002]CONDUCTED A STUDY
  ON VAGINAL MISOPROSTOL COMPARED
  WITH SURGICAL TREATMENT IN MISSED
  ABORTION & CLAIMED THAT 60%
  PATIENTS IN MISOPROSTOL GROUP
                                   23
DISCUSSION:
 NOT REQUIRED SURGICAL TREATMENT
  COMPARE TO 52% COMPLETE UTERINE
  EVACUATION IN OUR STUDY.
 ELSHEIKH,etal[2001] USED ORAL &
  VAGINAL MISOPROSTOL IN SECOND
  TRIMESTER MISSED ABORTION USING
  SAME DOSAGE AS IN OUR STUDY, MEAN
  INDUCTION TO EXPULTION TIME IS
  SAME &THE EFFICACY OF METHOD IS
  ALSO SIMILAR.                       24
CONCLUSION:
 VAGINAL MISOPROSTOL WAS FOUND
  MORE EFFECTIVE WITH LESSER SIDE
  EFFECTS AS COMPARE TO ORAL FOR
  MISSED ABORTION.
 IT IS OBSERVED IN OUR
                STUDY THAT
  MISOPROSTOL                  IS
  CHEAPER &
  EFFICIENT FOR
      MISSED ABORTION.              25
KEY POINTS:
   MISOPROSTOL HAS BEEN ON MARKET
    SINCE 1985 UNDER BRAND NAME OF
    CYTOTEC. IT IS AVAILABLE IN OVER 80
    COUNTRIES WORLD WIDE FOR
    TREATMENT OF GASTRIC

  ULCERS.
 MORE THAN 300
             ARTICLES HAVE BEEN
                                          26
KEY POINTS:
 USEFULNESS OF MISOPROSTOL IN NO.
  OF INDICATIONS IN OBS &
  GYNAECOLOGY.
 NO PROPER DOSAGE IS UPTILL
                             DECIDED
  &THE COMPANY

     NEVER APPLIED FOR
      APPROVAL FOR
               OBSTETRICS.             27
THANK YOU



     Lugansk State Medical University
  Block 50 years, Of lugansk defence, 1.
          Lugansk - 91045, Ukraine.
         email : info@lsmuedu.com /
             kanc@lsmuedu.com
Official website - http://www.lsmuedu.com
             +38-091-9484-428
                                            28

More Related Content

Similar to Vaginal oral misoprostol_lugansk-state-medical-university

Newer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholyticsNewer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholyticsShubham Marbade
 
A presentation on quinolones
A presentation on quinolonesA presentation on quinolones
A presentation on quinolonesProtic Jodder
 
Bisphosphonates bioavailability study
Bisphosphonates bioavailability studyBisphosphonates bioavailability study
Bisphosphonates bioavailability studynellysenecal
 
medical termination of pregnancy
medical termination of pregnancymedical termination of pregnancy
medical termination of pregnancySnehlata Parashar
 
raviobg-190225064935 2.pdf
raviobg-190225064935 2.pdfraviobg-190225064935 2.pdf
raviobg-190225064935 2.pdfSamridhi Bhargav
 
mtp-170513153856 (1) (1).pptx
mtp-170513153856 (1) (1).pptxmtp-170513153856 (1) (1).pptx
mtp-170513153856 (1) (1).pptxSachinSingh215159
 
Selective progesteron reuptake modualtors
Selective progesteron reuptake modualtorsSelective progesteron reuptake modualtors
Selective progesteron reuptake modualtorsDr. Rupendra Bharti
 
Karan swami Intranasal drug-delivery
Karan swami Intranasal drug-deliveryKaran swami Intranasal drug-delivery
Karan swami Intranasal drug-deliveryRahul Dalvi
 
Injectable Depot Preparations by Izharahemad Ansari
Injectable Depot Preparations by Izharahemad AnsariInjectable Depot Preparations by Izharahemad Ansari
Injectable Depot Preparations by Izharahemad AnsariIzharahemad Ansari
 
Evaluation of drugs acting on glaucoma & cataract by hiren
Evaluation of drugs acting on glaucoma & cataract by hirenEvaluation of drugs acting on glaucoma & cataract by hiren
Evaluation of drugs acting on glaucoma & cataract by hirenHiren Monapara
 
Misoprostol use in Obstetrics and Gynaecology
Misoprostol use in Obstetrics and GynaecologyMisoprostol use in Obstetrics and Gynaecology
Misoprostol use in Obstetrics and GynaecologyChimezie Obi
 
Laparoscopy for ovarian tumours in in pregnancy
Laparoscopy for ovarian tumours in  in pregnancy  Laparoscopy for ovarian tumours in  in pregnancy
Laparoscopy for ovarian tumours in in pregnancy Niranjan Chavan
 

Similar to Vaginal oral misoprostol_lugansk-state-medical-university (20)

Quinolones & Fluoroquinolones
Quinolones & FluoroquinolonesQuinolones & Fluoroquinolones
Quinolones & Fluoroquinolones
 
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholyticsNewer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
 
A presentation on quinolones
A presentation on quinolonesA presentation on quinolones
A presentation on quinolones
 
Bisphosphonates bioavailability study
Bisphosphonates bioavailability studyBisphosphonates bioavailability study
Bisphosphonates bioavailability study
 
Implants
ImplantsImplants
Implants
 
Uro gynacology- botox
Uro gynacology- botoxUro gynacology- botox
Uro gynacology- botox
 
medical termination of pregnancy
medical termination of pregnancymedical termination of pregnancy
medical termination of pregnancy
 
raviobg-190225064935 2.pdf
raviobg-190225064935 2.pdfraviobg-190225064935 2.pdf
raviobg-190225064935 2.pdf
 
mtp-170513153856 (1) (1).pptx
mtp-170513153856 (1) (1).pptxmtp-170513153856 (1) (1).pptx
mtp-170513153856 (1) (1).pptx
 
Selective progesteron reuptake modualtors
Selective progesteron reuptake modualtorsSelective progesteron reuptake modualtors
Selective progesteron reuptake modualtors
 
Karan swami Intranasal drug-delivery
Karan swami Intranasal drug-deliveryKaran swami Intranasal drug-delivery
Karan swami Intranasal drug-delivery
 
MTP
MTPMTP
MTP
 
Injectable Depot Preparations by Izharahemad Ansari
Injectable Depot Preparations by Izharahemad AnsariInjectable Depot Preparations by Izharahemad Ansari
Injectable Depot Preparations by Izharahemad Ansari
 
Atropine Dr-Z Pharmacy Practice
Atropine Dr-Z Pharmacy Practice Atropine Dr-Z Pharmacy Practice
Atropine Dr-Z Pharmacy Practice
 
Evaluation of drugs acting on glaucoma & cataract by hiren
Evaluation of drugs acting on glaucoma & cataract by hirenEvaluation of drugs acting on glaucoma & cataract by hiren
Evaluation of drugs acting on glaucoma & cataract by hiren
 
Alcipid
AlcipidAlcipid
Alcipid
 
Misoprostol use in Obstetrics and Gynaecology
Misoprostol use in Obstetrics and GynaecologyMisoprostol use in Obstetrics and Gynaecology
Misoprostol use in Obstetrics and Gynaecology
 
Laparoscopy for ovarian tumours in in pregnancy
Laparoscopy for ovarian tumours in  in pregnancy  Laparoscopy for ovarian tumours in  in pregnancy
Laparoscopy for ovarian tumours in in pregnancy
 
mtp.pptx
mtp.pptxmtp.pptx
mtp.pptx
 
Botox
BotoxBotox
Botox
 

Recently uploaded

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...RKavithamani
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 

Recently uploaded (20)

INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 

Vaginal oral misoprostol_lugansk-state-medical-university

  • 1. EFFICACY OF VAGINAL VS. ORAL MISOPROSTOL FOR INDUCTION OF LABOR IN MISSED ABORTION PRESENTED BY Lugansk State Medical University Block 50 years, Of lugansk defence, 1. Lugansk - 91045, Ukraine. email : info@lsmuedu.com / kanc@lsmuedu.com Official website - http://www.lsmuedu.com 1 +38-091-9484-428
  • 2. OBJECTIVES  TO DETERMINE THE EFFICACY OF VAGINAL VS. ORAL MISOPROSTOL AS A LABOR INDUCING AGENT IN MISSED ABORTION. 2
  • 3. INTRODUCTION  MISSED ABORTION IS THE FAILURE TO EXPEL THE PRODUCTS OF CONCEPTION AFTER DEATH OF EMBRYO.  MISSED ABORTION IS MANAGED EITHER BY SURGICAL & NON SURGICAL METHODS.  IN RECENT YEARS MISOPROSTOL,A SYNTHETIC PGE1, ANALOGUE, IS BEING 3 EVALUATED FOR LABOR INDUCTION.
  • 4. 4
  • 5. INTRODUCTION:  MISOPROSTOL CAN BE GIVEN ORALLY, SUBLINGUALLY, VAGINALLY OR RECTALLY.  IT HAS BEEN EXTENSIVELY STUDIED & USED FOR OBSTETRICAL & GYNAECOLOGICAL CAUSES, SUCH AS PRE-INDUCTION CERVICAL RIPENING, LABOR INDUCTION, EVACUATION OF UTERUS AFTER PREGNANCY FAILURE OR VARIOUS MEDICAL REASONS. 5
  • 6. DESIGN  A QUASI EXPERIMENTAL STUDY. 6
  • 7. SUBJECT &SETTING:  THIS STUDY WAS PERFORMED IN GYNAE/OBS UNIT II IN HOLY FAMILY HOSPITAL RAWALPINDI [PAKISTAN].  35 PATIENTS IN VAGINAL MISOPROSTOL GROUP & 35 PATIENTS IN ORAL MISOPROSTOL GROUP WERE STUDIED. 7
  • 8. METHOD:  TOTAL OF 70 PREGNANT WOMEN ADMITTED WITH MISSED ABORTION OR BLIGHTED OVUM OF 8wks TO 24wks OF GESTATION DURING THE PERIOD OF JUNE 2005 TO NOV 2005.  MISSED ABORTION WAS CONFIRMED ON ULTRASOUND.  INITIAL EVALUATION OF PTS WAS DONE.  CONSENT OF PATIENT. 8
  • 9. METHODS:  THE CASES WERE RANDOMIZED IN TWO GROUPS.  ONE FOR ORAL MISOPROSTOL & OTHER FOR VAGINAL MISOPROSTOL.  IN ONE GROUP 400ug WAS INSERTED UNDER FULL ASEPTIC CONDITIONS HIGH UP IN POSTERIOR FORNIX OF VAGINA WHILE IN SECOND GROUP PATIENT TAKE IT ORALLY. 9
  • 10. 10
  • 11. METHODS:  THE DOSE OF MISOPROSTOL WAS REPEATED AFTER EVERY 4hrs TO A MAX. OF FOUR DOSES IN 24 hrs.  IF COMPLETE EXPULSION DID NOT OCCUR WITH IN 48hrs & IF PATIENT BLEED HEAVILY THEN ERPC WAS DONE.  FOLLOW UP. 11
  • 12. RESULTS: [PATIENTS DISTRIBUTION IN BOTH GROUP]  35  35 Vaginal Misoprostol ORAL Misoprostol 12
  • 13. RESULTS [AGE OF PATIENT] 80 70 60 50 40 30 20 10 0 <20 years 20-30 years >35 years Oral Misoprostol Vaginal Misoprostol 13
  • 14. RESULTS: [PARITY]  60 50 40 30 20 Oral 10 Misoprostol 0 Prim igravida Vaginal Misoprostol 14
  • 15. RESULTS: VAGINAL ORAL Misoprostol Misoprostol GROUP GROUP MEAN INDUCTION TO 9.16 HRS 12.09HRS EXPULSION TIME 15
  • 16. RESULTS: [INDUCTION TO EXPULSION TIME]  16 Oral Misoprostol Vaginal Misoprostol
  • 17. RESULTS: OTHER VAGINAL ORAL GROUP MEASURE GROUP 3% 7% ERPC [REQUIRED] 21% 27% COMPLETE EXPULTION 52% 28% 17
  • 18. RESULTS: [REQUIREMENT FOR ERPC IN BOTH GROUP]  52 51 50 49 48 . 47 46 ERPC 18 Oral misoprostol Vaginal Misoprostol
  • 19. RESULTS: [REQUIRMENT OF OXYTOCIN AUGMENTATION] Vaginal Misoprostol Oral Misoprostol Oral Misoprostol Vaginal Misoprostol 19
  • 20. RESULTS: [COMPARISON OF ERPC & OXYTOCIN FOR COMPLETE EVACUATION] 100% 80% 60% 40% 20% 0% Oral Misoprostol Vaginal Misoprostol 20
  • 21. COMPLICATIONS: [IN BOTH GROUPS]  Vaginal Misoprostol Oral Misoprostol termination complication fever vomoting diarrhoea faild no Oral Misoprostol Vaginal Misoprostol 21
  • 22. DISCUSSION:  TERMINATION OF PREGNANCY IS AN INTEGRAL PART OF ANY GYNAECOLOGICAL PRACTICE.  DIFFERENT METHODS OF CERVICAL RIPENING HAVE BEEN USED WITH VARIABLE RESULTS.  CHOHAN,etal, HAVE DONE A STUDY USING EXTRA AMNIOTIC PGF2 alpha FOR MID TRIMESTER INDUCTION OF LABOR IN PTS WITH LATE MISSED ABORTION. 22
  • 23. DISCUSSION:  THEY CLAIMED THAT 100% EXPULSION RATE WHICH IS COMPARABLE TO 94% EXPULSION RATE OBSERVED IN OUR STUDY.  MUFFLEY PE,[2002]CONDUCTED A STUDY ON VAGINAL MISOPROSTOL COMPARED WITH SURGICAL TREATMENT IN MISSED ABORTION & CLAIMED THAT 60% PATIENTS IN MISOPROSTOL GROUP 23
  • 24. DISCUSSION:  NOT REQUIRED SURGICAL TREATMENT COMPARE TO 52% COMPLETE UTERINE EVACUATION IN OUR STUDY.  ELSHEIKH,etal[2001] USED ORAL & VAGINAL MISOPROSTOL IN SECOND TRIMESTER MISSED ABORTION USING SAME DOSAGE AS IN OUR STUDY, MEAN INDUCTION TO EXPULTION TIME IS SAME &THE EFFICACY OF METHOD IS ALSO SIMILAR. 24
  • 25. CONCLUSION:  VAGINAL MISOPROSTOL WAS FOUND MORE EFFECTIVE WITH LESSER SIDE EFFECTS AS COMPARE TO ORAL FOR MISSED ABORTION.  IT IS OBSERVED IN OUR STUDY THAT MISOPROSTOL IS CHEAPER & EFFICIENT FOR MISSED ABORTION. 25
  • 26. KEY POINTS:  MISOPROSTOL HAS BEEN ON MARKET SINCE 1985 UNDER BRAND NAME OF CYTOTEC. IT IS AVAILABLE IN OVER 80 COUNTRIES WORLD WIDE FOR TREATMENT OF GASTRIC ULCERS.  MORE THAN 300 ARTICLES HAVE BEEN 26
  • 27. KEY POINTS:  USEFULNESS OF MISOPROSTOL IN NO. OF INDICATIONS IN OBS & GYNAECOLOGY.  NO PROPER DOSAGE IS UPTILL DECIDED &THE COMPANY NEVER APPLIED FOR APPROVAL FOR OBSTETRICS. 27
  • 28. THANK YOU Lugansk State Medical University Block 50 years, Of lugansk defence, 1. Lugansk - 91045, Ukraine. email : info@lsmuedu.com / kanc@lsmuedu.com Official website - http://www.lsmuedu.com +38-091-9484-428 28